News

20 Nov: Ontario Names Molly Shoichet the Province’s First Chief Scientist

Ontario has appointed Molly Shoichet to advance science and innovation in the province — and to make government smarter and more effective by providing decision-makers with the world’s best scientific research and evidence. The Chief Scientist will advise Premier Kathleen Wynne directly on key scientific matters, demonstrating Ontario’s ongoing commitment…

13 Jun: Eurofins Expands Its Leadership in Biopharmaceutical Services with the Acquisition of Alphora Research, Inc.

Eurofins Scientific (Paris:ERF) (EUFI.PA), a world leader in biopharmaceutical testing, announces the acquisition of Alphora Research Inc. (“Alphora”), a full service contract research, development and manufacturing organization (CRDMO) for complex and niche small molecule active pharmaceutical ingredients (APIs), based in Mississauga, Ontario, Canada. Alphora has extensive capabilities in multi-step syntheses,…

13 Jun: BIO2016: Showcasing Ontario innovation to the world

LSO coordinated Ontario’s presence at the BIO International Convention in San Francisco from June 6-9, in conjunction with the Ministry of Research and Innovation. To give an idea of the scope and impact of this convention, BIO2016 was attended by approximately 16,000 delegates from 76 countries, and facilitated a record 35,700 partnering meetings….

17 Feb: Accel-Rx/BDC make second portfolio investment in ScarX Therapeutics

Company completing Phase 1 human clinical trial of drug to prevent dermal scarring VANCOUVER (February 16, 2016) — Accel-Rx Health Sciences Accelerator (Accel-Rx), a Centre of Excellence for the Commercialization of Research (CECR), and its partner BDC Capital today announced their second joint investment in ScarX Therapeutics, a Canadian biotechnology…